Founding Partner at Ahren Innovation Capital · Joined 2018
View Live Interactive Profile →Professor Steve Jackson is a Founding Partner of Ahren Innovation Capital, named among the Founding Science Partners at the firm's September 2018 launch. Ahren's team page credits him as the originator of Olaparib/Lynparza, which it values at up to $17BN. He heads the Cancer Research UK Laboratories and is an expert in DNA repair. He is a Fellow of the Royal Society. Ahren does not publish his degrees or board seats.